CLDI
Price
$0.73
Change
-$0.04 (-5.19%)
Updated
Jul 25 closing price
Capitalization
25.2M
GNNSF
Price
$2.31
Change
+$0.19 (+8.96%)
Updated
Jul 24 closing price
Capitalization
4.96B
Interact to see
Advertisement

CLDI vs GNNSF

Header iconCLDI vs GNNSF Comparison
Open Charts CLDI vs GNNSFBanner chart's image
Calidi Biotherapeutics
Price$0.73
Change-$0.04 (-5.19%)
Volume$2.75M
Capitalization25.2M
Genscript Biotech
Price$2.31
Change+$0.19 (+8.96%)
Volume$215
Capitalization4.96B
CLDI vs GNNSF Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. GNNSF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and GNNSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CLDI: $0.73 vs. GNNSF: $2.31)
Brand notoriety: CLDI and GNNSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 14% vs. GNNSF: 26%
Market capitalization -- CLDI: $25.2M vs. GNNSF: $4.96B
CLDI [@Biotechnology] is valued at $25.2M. GNNSF’s [@Biotechnology] market capitalization is $4.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileGNNSF’s FA Score has 0 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • GNNSF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLDI and GNNSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 5 TA indicator(s) are bullish while GNNSF’s TA Score has 4 bullish TA indicator(s).

  • CLDI’s TA Score: 5 bullish, 5 bearish.
  • GNNSF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, GNNSF is a better buy in the short-term than CLDI.

Price Growth

CLDI (@Biotechnology) experienced а +22.98% price change this week, while GNNSF (@Biotechnology) price change was +8.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

CLDI is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF($4.96B) has a higher market cap than CLDI($25.2M). GNNSF YTD gains are higher at: 81.614 vs. CLDI (-36.522). CLDI has higher annual earnings (EBITDA): -17.73M vs. GNNSF (-203.82M). GNNSF has more cash in the bank: 1.87B vs. CLDI (10.6M). CLDI has less debt than GNNSF: CLDI (4.71M) vs GNNSF (448M). GNNSF has higher revenues than CLDI: GNNSF (1.01B) vs CLDI (0).
CLDIGNNSFCLDI / GNNSF
Capitalization25.2M4.96B1%
EBITDA-17.73M-203.82M9%
Gain YTD-36.52281.614-45%
P/E RatioN/AN/A-
Revenue01.01B-
Total Cash10.6M1.87B1%
Total Debt4.71M448M1%
FUNDAMENTALS RATINGS
GNNSF: Fundamental Ratings
GNNSF
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
47
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDIGNNSF
RSI
ODDS (%)
Bearish Trend 2 days ago
17%
Bearish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 3 days ago
51%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
31%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSCIX13.410.10
+0.75%
AMG TimesSquare Small Cap Growth Z
VSMAX118.190.72
+0.61%
Vanguard Small Cap Index Admiral Shares
TBDZX20.960.09
+0.43%
PGIM Jennison Diversified Growth Z
GTHIX36.140.13
+0.36%
Invesco Health Care Invstor
INSLX43.69-0.01
-0.02%
Invesco International Small-Mid Com R5

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with ORYZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then ORYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
-5.43%
ORYZF - CLDI
37%
Loosely correlated
N/A
DYN - CLDI
36%
Loosely correlated
+7.68%
LENZ - CLDI
32%
Poorly correlated
-5.33%
RYTM - CLDI
30%
Poorly correlated
-0.94%
PROK - CLDI
29%
Poorly correlated
+0.92%
More

GNNSF and

Correlation & Price change

A.I.dvisor tells us that GNNSF and ORYZF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNNSF and ORYZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
CLDI - GNNSF
23%
Poorly correlated
-5.43%
PRLD - GNNSF
20%
Poorly correlated
N/A
HNSBF - GNNSF
17%
Poorly correlated
N/A
More